-
-
2.
公开(公告)号:EP4085928A1
公开(公告)日:2022-11-09
申请号:EP22169086.0
申请日:2017-12-13
IPC分类号: A61K39/12 , A61K39/155 , A61K39/245 , A61K39/295 , C07K14/03 , C07K14/08 , C12N7/00
摘要: The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors and polyvalent vaccines comprising the recombinant HVT vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.
-
-
公开(公告)号:EP3528842A1
公开(公告)日:2019-08-28
申请号:EP17804329.5
申请日:2017-10-20
申请人: Boehringer Ingelheim Animal Health USA Inc. , The United States of America, as Represented by the Secretary of Agriculture
IPC分类号: A61K39/145 , A61K39/00
-
公开(公告)号:EP4112073A1
公开(公告)日:2023-01-04
申请号:EP22174415.4
申请日:2012-11-29
IPC分类号: A61K39/12
摘要: The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors, polyvalent vaccines comprising the recombinant HVT vectors and one or more wild type viruses or recombinant vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.
-
6.
公开(公告)号:EP3854415A1
公开(公告)日:2021-07-28
申请号:EP21151205.8
申请日:2017-12-13
IPC分类号: A61K39/12 , A61K39/155 , A61K39/245 , A61K39/295 , C07K14/03 , C07K14/08 , C12N7/00
摘要: The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors and polyvalent vaccines comprising the recombinant HVT vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.
-
公开(公告)号:EP3578199A1
公开(公告)日:2019-12-11
申请号:EP19167407.6
申请日:2012-11-29
摘要: The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors, polyvalent vaccines comprising the recombinant HVT vectors and one or more wild type viruses or recombinant vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.
-
8.
公开(公告)号:EP4112072A1
公开(公告)日:2023-01-04
申请号:EP22169088.6
申请日:2017-12-13
IPC分类号: A61K39/12 , A61K39/155 , A61K39/245 , A61K39/295 , C07K14/03 , C07K14/08 , C12N7/00
摘要: The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors and polyvalent vaccines comprising the recombinant HVT vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.
-
9.
公开(公告)号:EP3744342A1
公开(公告)日:2020-12-02
申请号:EP20177566.5
申请日:2017-12-13
IPC分类号: A61K39/12 , A61K39/155 , A61K39/245 , A61K39/295 , C07K14/03 , C07K14/08 , C12N7/00
摘要: The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors and polyvalent vaccines comprising the recombinant HVT vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.
-
公开(公告)号:EP4378528A2
公开(公告)日:2024-06-05
申请号:EP24161475.9
申请日:2017-10-20
申请人: Boehringer Ingelheim Animal Health USA Inc. , The United States of America as represented by the Secretary of Agriculture
IPC分类号: A61P31/16
CPC分类号: A61K39/145 , A61K2039/525620130101 , A61P31/16 , C12N2760/1613420130101 , C12N2760/1612220130101 , C12N2710/1634320130101 , C12N2710/2404320130101 , C12N15/86
摘要: The present invention provides recombinant viral vectors that contain and express an avian influenza virus antigen and a pharmaceutical composition or vaccine comprising the recombinant viral vector. The present invention further provides methods of vaccination against an avian influenza pathogen.
-
-
-
-
-
-
-
-
-